Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gastl

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|July 7, 1999
Vascular endothelial growth factor platelet counts and renal cancerE Gunsilius, A L Petzer, G Gastl
Clinical and Experimental Immunology|September 1, 1984
The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killingH Rumpold, D Kraft, G Gastl, et al.
Onkologie|May 13, 2004
Low-dose thalidomide for multiple myeloma: interim analysis of a compassionate use programM Steurer, G Spizzo, M Mitterer, et al.
Clinical and Experimental Immunology|November 25, 2003
Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodiesB Kircher, K Lätzer, G Gastl, et al.
Onkologie|June 1, 1984
[Long-term osteoporosis with multiple fractures as the early monosymptomatic stage of multiple myeloma]K Abbrederis, C Gattringer, P König, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Symposium on health economics in oncology. Freiburg, Germany, June 1995A L Kranich, G Gastl, E Druckrey, et al.
British Journal of Haematology|July 23, 1998
Differential activity of P-glycoprotein in normal blood lymphocyte subsetsC Ludescher, G Pall, E U Irschick, et al.
Blut|June 1, 1983
Large granular lymphocytes: morphological and functional properties. I. Results in normalsG Gastl, F Schmalzl, D Huhn, et al.
Blut|December 1, 1982
[Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue]C Huber, D Niederwieser, G Gastl, et al.
Lancet (London, England)|December 29, 2000
Ep-CAM overexpression in breast cancer as a predictor of survivalG Gastl, G Spizzo, P Obrist, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|July 7, 1999
Vascular endothelial growth factor platelet counts and renal cancerE Gunsilius, A L Petzer, G Gastl
Clinical and Experimental Immunology|September 1, 1984
The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killingH Rumpold, D Kraft, G Gastl, et al.
Onkologie|May 13, 2004
Low-dose thalidomide for multiple myeloma: interim analysis of a compassionate use programM Steurer, G Spizzo, M Mitterer, et al.
Clinical and Experimental Immunology|November 25, 2003
Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodiesB Kircher, K Lätzer, G Gastl, et al.
Onkologie|June 1, 1984
[Long-term osteoporosis with multiple fractures as the early monosymptomatic stage of multiple myeloma]K Abbrederis, C Gattringer, P König, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Symposium on health economics in oncology. Freiburg, Germany, June 1995A L Kranich, G Gastl, E Druckrey, et al.
British Journal of Haematology|July 23, 1998
Differential activity of P-glycoprotein in normal blood lymphocyte subsetsC Ludescher, G Pall, E U Irschick, et al.
Blut|June 1, 1983
Large granular lymphocytes: morphological and functional properties. I. Results in normalsG Gastl, F Schmalzl, D Huhn, et al.
Blut|December 1, 1982
[Density distribution of human lymphocytes. I. Results of research on normal lymphoid tissue]C Huber, D Niederwieser, G Gastl, et al.
Lancet (London, England)|December 29, 2000
Ep-CAM overexpression in breast cancer as a predictor of survivalG Gastl, G Spizzo, P Obrist, et al.
Pageof 14